End-of-day quote
Korea S.E.
18:00:00 2024-05-30 EDT
|
5-day change
|
1st Jan Change
|
41,500
KRW
|
-0.36%
|
|
+13.39%
|
-23.15%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
418,266
|
913,616
|
717,959
|
-
|
Enterprise Value (EV)
2 |
418.3
|
913.1
|
764
|
799
|
P/E ratio
|
-20
x
|
-22.5
x
|
-24.1
x
|
-21.9
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
55.2
x
|
39.9
x
|
EV / Revenue
|
-
|
-
|
58.8
x
|
44.4
x
|
EV / EBITDA
|
-
|
-31.9
x
|
-34.7
x
|
-34.7
x
|
EV / FCF
|
-
|
-29.7
x
|
-25.5
x
|
-23.5
x
|
FCF Yield
|
-
|
-3.36%
|
-3.93%
|
-4.26%
|
Price to Book
|
-
|
10.2
x
|
-20
x
|
-9.83
x
|
Nbr of stocks (in thousands)
|
14,698
|
16,919
|
17,300
|
-
|
Reference price
3 |
28,458
|
54,000
|
41,500
|
41,500
|
Announcement Date
|
3/23/23
|
2/15/24
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
-
|
13
|
18
|
EBITDA
1 |
-
|
-28.64
|
-22
|
-23
|
EBIT
1 |
-
|
-31.34
|
-23
|
-24
|
Operating Margin
|
-
|
-
|
-176.92%
|
-133.33%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
1 |
-19.9
|
-36.85
|
-30
|
-32
|
Net margin
|
-
|
-
|
-230.77%
|
-177.78%
|
EPS
2 |
-1,426
|
-2,401
|
-1,724
|
-1,891
|
Free Cash Flow
3 |
-
|
-30,700
|
-30,000
|
-34,000
|
FCF margin
|
-
|
-
|
-230,769.23%
|
-188,888.89%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/23/23
|
2/15/24
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
46
|
81
|
Net Cash position
1 |
-
|
0.56
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-2.091
x
|
-3.522
x
|
Free Cash Flow
2 |
-
|
-30,700
|
-30,000
|
-34,000
|
ROE (net income / shareholders' equity)
|
-
|
-63.9%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-46.5%
|
-41.1%
|
-56.4%
|
Assets
1 |
-
|
79.3
|
72.99
|
56.74
|
Book Value Per Share
3 |
-
|
5,301
|
-2,078
|
-4,222
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/23/23
|
2/15/24
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
41,500
KRW Average target price
85,000
KRW Spread / Average Target +104.82% Consensus |
1st Jan change
|
Capi.
|
---|
| -23.15% | 519M | | +43.36% | 54.64B | | -5.31% | 39.92B | | +37.52% | 38.82B | | +14.75% | 26.86B | | -12.56% | 26.22B | | -22.45% | 18.78B | | +25.12% | 12.21B | | +0.04% | 12.16B | | +26.04% | 11.94B |
Other Biotechnology & Medical Research
|